Article
APTIMA mRNA vs. DNA-Based HPV Assays: Analytical Performance Insights from a Resource-Limited South African Setting.
International journal of molecular sciences - 1 Aug 2025
Nkwinika Varsetile Varster, Amissah Kelvin Amoh, Rakgole Johnny Nare, Khaba Moshawa Calvin, Magwira Cliff Abdul, Lebelo Ramokone Lisbeth
Abstract excerpt
Cervical cancer remains a major health burden among women in sub-Saharan Africa, where screening is often limited. Persistent high-risk human papillomavirus (HR-HPV) infection is the principal cause, highlighting the need for accurate molecular diagnostics. This cross-sectional study evaluated the analytical performance of one mRNA assay, APTIMA® HPV assay (APTIMA mRNA), and two DNA-based assays, the Abbott...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
